Health Affairs, 28, no. 5 (2009): 1366-1371
doi: 10.1377/hlthaff.28.5.1366
© 2009 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Comments: View responses
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
Google Scholar
* Articles by Neumann, P. J.
* Articles by Greenberg, D.
PubMed
* PubMed Citation
* Articles by Neumann, P. J.
* Articles by Greenberg, D.
Related Collections
* Health Reform
* International Issues
* Quality Of Care
* Health Spending

Perspective

PERSPECTIVE

Is The United States Ready For QALYs?

Peter J. Neumann and Dan Greenberg

Quality-adjusted life-years (QALYs) are used in cost-effectiveness analyses to aid coverage and reimbursement decisions worldwide. QALYs provide a flexible and convenient metric for measuring and comparing health outcomes across diverse diseases and treatments. But their use has stirred controversy about how accurately they reflect preferences for health care and whether their use is fair. We review the debate and the use of QALYs in other countries and discuss prospects for using them in the U.S. health care system. Strict adherence to a QALY approach is likely to prove unacceptable in the United States, but a more flexible use of QALYs could be beneficial.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
D. Greenberg, C. Earle, C.-H. Fang, A. Eldar-Lissai, and P. J. Neumann
When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
J Natl Cancer Inst, January 20, 2010; 102(2): 82 - 88.
[Abstract] [Full Text] [PDF]

Comments:

Read all Comments

More On The Use Of QALYs
Markus Lungen, et al.
Health Affairs, 11 Sep 2009 [Full text]
A Distorted Picture Of The IQWiG Methodology
Andreas U. Gerber, et al.
Health Affairs, 18 Sep 2009 [Full text]